Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04887129 · ClinicalTrials.gov registry record · NA
Testing for COVID-19 in High Risk Children With Intellectual and Developmental Disabilities (COV-IDD)
A NA study, sponsored by University of Rochester.
- Completed
- Registry status
- NA
- Development phase
- 392
- Enrollment target
NCT04887129: Completed NA study, sponsored by University of Rochester.
NCT04887129 is a NA study that has completed, run by University of Rochester. The registered enrollment target is 392 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (72% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04887129, a NA study, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- NA
- Development phase
- 392 participants
- Enrollment target
Study Summary
The purpose of this study is to understand how to prevent COVID-19 spread in a school like the Mary Cariola Center (MCC) in Rochester, NY by answering questions like these: how do activities in the school alter chances of infection? Are there people infected with the COVID-19 virus who have no symptoms? How is spread of COVID-19 affected by vaccination rates? Is there any hesitancy to get the vaccine and what are the reasons? This information will be used to help keep the school open and the students and staff safe. Eligible participants are those that work at the Mary Cariola Center (MCC) and interact with the students at MCC who have a high risk of infection from COVID-19. The study lasts for up to 16 months.
Primary Outcome
Number of students or staff who test positive for COVID-19 at least once using a nasal swab test.
Interventions
- DIAGNOSTIC_TEST COVID-19 RT-PCR test
- OTHER COVID-19 Vaccine Education Campaign
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 392 participants |
| Start Date | 2021-05-03 |
| Est. Completion | 2024-03-31 |
| Phase | NA |
What the finished NCT04887129 record still lists
NCT04887129 is an interventional study that assigns participants to a tested intervention. The registered 392 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (72% lower).
The record links to 0 conditions, and to 2 interventions - of which COVID-19 RT-PCR test is the first listed.
NCT04887129 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04887129 about?
NCT04887129 is a clinical study titled "Testing for COVID-19 in High Risk Children With Intellectual and Developmental Disabilities (COV-IDD)". The purpose of this study is to understand how to prevent COVID-19 spread in a school like the Mary Cariola Center (MCC) in Rochester, NY by answering questions like these: how do activities in the school alter chances of infection? Are there people infected with the COVID-19 virus who have no sympt...
What is the current status of trial NCT04887129?
This trial is currently completed. It is a NA study. The enrollment target is 392 participants. The study started on 2021-05-03. Estimated completion is 2024-03-31.
What interventions are being tested in trial NCT04887129?
The interventions under investigation include: COVID-19 RT-PCR test (DIAGNOSTIC_TEST), COVID-19 Vaccine Education Campaign (OTHER).
Who is sponsoring clinical trial NCT04887129?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04887129's enrollment target sits among peer trials
392 269th of 2000 higher than 1,732 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06397703 · 392 participants · Phase 2
ADT and SBRT vs SBRT Alone for Unfavorable Intermediate Risk Prostate Cancer
- NCT06625775 · 392 participants · Phase 1
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
- NCT07220967 · 392 participants · Phase 4
A Study of Antibiotic Delivery to Prevent Infection After Breast Tissue Expander Placement
- NCT07290036 · 392 participants · Phase 1
A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI